Upgrade to SI Premium - Free Trial

GeneDx (WGS) PT Raised to $74 at Guggenheim

June 29, 2026 6:55 AM
Guggenheim analyst Subbu Nambi raised the price target on GeneDx (NASDAQ: WGS) to $74.00 (from $70.00) while maintaining a Buy rating.

Categories

Analyst PT Change